What is the status of gene therapy for primary immunodeficiency?

Author：

ISSN： 0257-277X

Source： Immunologic Research, Vol.38, Iss.1-3, 2007-07, pp. : 274-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years

By Leonard W.J.

Molecular Medicine Today, Vol. 6, Iss. 10, 2000-10 ,pp. : 403-407

Elsevier

Access to resources Recommend Favorite

Was it justified?

By Heron John

Australasian Physical & Engineering Sciences in Medicine, Vol. 34, Iss. 1, 2011-04 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis G virus (HGV): where we stand and what to do?

By Ahmed Q. Mughis Uddin

International Journal of Immunological Studies, Vol. 1, Iss. 3, 2011-08 ,pp. : 255-263

Inderscience Publishers

Access to resources Recommend Favorite

Diagnostic approaches for identifying acute graft-versus-host disease: what comes next?

By Martino Massimo Recchia Anna Grazia Gentile Massimo Morabito Lucio Vigna Ernesto Cuzzola Maria Morabito Fortunato

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 553-556

Future Medicine

Access to resources Recommend Favorite

B-lymphocyte therapy for Type 2 diabetes: the `B' side of diabetic medication?

By Grey Shane T

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 669-672

Future Medicine

Access to resources Recommend Favorite